PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: A meta-analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 5, 2015, Pages 821-829

  Zhang, Long ^a   You, Wei ^a   Zhang, Hanze ^b   Peng, Rui ^a   Zhu, Qin ^a   Yao, Aihua ^a   Li, Xiangcheng ^a   Zhou, Yebin ^c   Wang, Xuehao ^a   Pu, Liyong ^a   Wu, Jindao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b University of South Tampa   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

ALT; Asian population; Meta analysis; NAFLD; PNPLA3

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 PROTEIN; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ARTICLE; ASIAN; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; LIVER FIBROSIS; META ANALYSIS; NONALCOHOLIC FATTY LIVER; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; BIBLIOGRAPHIC DATABASE; BLOOD; CASE CONTROL STUDY; FIBROSIS; GENETIC PREDISPOSITION; GENETICS; LIVER; PATHOLOGY; RISK; RISK FACTOR;

ALANINE TRANSAMINASE; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DATABASES, BIBLIOGRAPHIC; FIBROSIS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPASE; LIVER; MEMBRANE PROTEINS; NON-ALCOHOLIC FATTY LIVER DISEASE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; RISK FACTORS;

EID: 84926635029     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12889     Document Type: Article

References (46)

1. Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002; 346: 1221-1231.
2. Lee JY, Kim KM, Lee SG etal. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J. Hepatol. 2007; 47: 239-244.
3. Attar BM, Van Thiel DH. Current concepts and management approaches in nonalcoholic fatty liver disease. Scientific World Journal 2013; 2013: 481893.
4. Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J. Gastroenterol. Hepatol. 2013; 28 (Suppl. 1): 11-17.
5. Farrell GC, Wong VW, Chitturi S. NAFLD NAFLD in Asia-as common and important as in the West. Nat Rev Gastroenterol Hepatol 2013; 10: 307-318.
6. Hou XH, Zhu YX, Lu HJ etal. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. J. Gastroenterol. Hepatol. 2011; 26: 722-730.
7. Schwimmer JB, Celedon MA, Lavine JE etal. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009; 136: 1585-1592.
8. Anstee QM, Daly AK, Day CP. Genetics of alcoholic and nonalcoholic fatty liver disease. Semin. Liver Dis. 2011; 31: 128-146.
9. Yuan X, Waterworth D, Perry JR etal. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. 2008; 83: 520-528.
10. Romeo S, Kozlitina J, Xing C etal. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 2008; 40: 1461-1465.
11. Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ. Characterization of the human patatin-like phospholipase family. J. Lipid Res. 2006; 47: 1940-1949.
12. Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S, Valent L. PNPLA3 I148M polymorphism and progressive liver disease. World J. Gastroenterol. 2013; 19: 6969-6978.
13. Sookoian S, Castano GO, Burgueno AL, Gianotti TF, Rosselli MS, Pirola CJ. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J. Lipid Res. 2009; 50: 2111-2116.
14. Speliotes EK, Butler JL, Palmer CD etal. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010; 52: 904-912.
15. Kitamoto T, Kitamoto A, Yoneda M etal. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum. Genet. 2013; 132: 783-792.
16. Peng XE, Wu YL, Lin SW, Lu QQ, Hu ZJ, Lin X. Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population. PLoS ONE 2012; 7: e50256.
17. Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene PNPLA3 on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011; 53: 1883-1894.
18. von Elm E, Altman DG, Egger M etal. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
19. von Elm E, Altman DG, Egger M etal. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007; 4: e296. Review.
20. von Elm E, Altman DG, Egger M etal. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann. Intern. Med. 2007; 147: 573-577.
21. von Elm E, Altman DG, Egger M etal. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007; 18: 800-804.
22. von Elm E, Altman DG, Egger M etal. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev. Med. 2007; 45: 247-251.
23. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 2011; 43: 617-649.
24. Mega JL, Simon T, Collet JP etal. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA 2010; 304: 1821-1830.
25. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann. Intern. Med. 1997; 127: 820-826.
26. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst. 1959; 22: 719-748.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-188.
28. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
29. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
30. Hotta K, Yoneda M, Hyogo H etal. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med. Genet. 2010; 11: 172.
31. Lin YC, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J. Pediatr. 2011; 158: 740-744.
32. Wang CW, Lin HY, Shin SJ etal. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int. 2011; 31: 1326-1331.
33. Kawaguchi T, Sumida Y, Umemura A etal. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 2012; 7: e38322.
34. Li Y, Xing C, Tian Z, Ku HC. Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population. BMC Med. Genet. 2012; 13: 113.
35. Zain SM, Mohamed R, Mahadeva S, Cheah PL, Rampal S etal. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. Hum. Genet. 2012; 131: 1145-1152.
36. Kasturiratne A, Akiyama K, Niriella MA etal. Association of genetic variants with non-alcoholic fatty liver disease in an urban Sri Lankan community. Liver Int. 2014; 35: 676-679.
37. Lin YC, Chang PF, Chang MH, Ni YH. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. Am. J. Clin. Nutr. 2014; 99: 869-874.
38. Niu TH, Jiang M, Xin YN, Jiang XJ, Lin ZH, Xuan SY. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population. World J. Gastroenterol. 2014; 20: 3655-3662.
39. Shen J, Wong GL, Chan HL etal. PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2014; 30: 139-146.
40. Xu J, Xin YN, Lu WH etal. Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2013; 21: 619-623.
41. He S, McPhaul C, Li JZ etal. A sequence variation I148M in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 2010; 285: 6706-6715.
42. Pirazzi C, Adiels M, Burza MA etal. Patatin-like phospholipase domain-containing 3 PNPLA3 I148M rs738409 affects hepatic VLDL secretion in humans and in vitro. J. Hepatol. 2012; 57: 1276-1282.
43. Kumari M, Schoiswohl G, Chitraju C etal. Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab. 2012; 15: 691-702.
44. Basantani MK, Sitnick MT, Cai L etal. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J. Lipid Res. 2011; 52: 318-329.
45. Li JZ, Huang Y, Karaman R etal. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J. Clin. Invest. 2012; 122: 4130-4144.
46. Chen W, Chang B, Li L, Chan L. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 2010; 52: 1134-1142.